Ropes & Gray LLP

Ropes & Gray LLP

Ropes & Gray LLP

Overview
Date Founded

2009

Headquarters

1 Metro Center,700 12th Street NW,Suite 900,Washington, DC 20005-3948

Type of Company

Private

Employees (Worldwide)

1,001 - 5,000

Industries

Legal
Other Business & Consulting Services
Investment Services & Portfolio Management

Company Description

Ropes & Gray LLP is a global law firm with 11 offices located in the United States, Asia, and Europe. The firm has over 1,100 lawyers, and professionals worldwide, and its clients include corporations and financial institutions, government agencies, universities, and health care organizations. It was founded in 1865 in Boston, Massachusetts by John Codman Ropes and John Chipman Gray

Contact Data
Trying to get in touch with decision makers at Ropes & Gray LLP? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

Co-Founder

Owner & Realtor

Chair

Co-Managing Partner

Managing Partner

Managing Partner

Managing Partner

Managing Partner

Co-Managing Partner

Managing Partner

Paths to Ropes & Gray LLP
Potential Connections via
Relationship Science
You
Ropes & Gray LLP
Recent Transactions
Details Hidden

Dragoneer Growth Opportunities Corp. issued USD Units Consisting of Ordinary Shares and Warrants

Details Hidden

Seres Therapeutics, Inc. issued USD Common Stock

Details Hidden

Quanterix Corp. issued USD Common Stock

Transaction Clients
Legal Advisor

Advised on Regeneron Pharmaceuticals, Inc. issued USD Common Stock

Legal Advisor

Advised on Verizon Communications, Inc., Vodafone Group Plc, Verizon Wireless, Inc. purchase Alltel Corp. from GS Capital Partners LP, TPG Capital, LP, Atlantis Holdings LLC

Legal Advisor

Advised on Regeneron Pharmaceuticals, Inc. issued USD Common Stock

Advisors & Consultants
Legal Advisor

Partner at Proskauer Rose LLP

Legal Advisor

Former Chairman at Ropes & Gray LLP

Agent

Partner at Dragone Realty Investments LLC

Clients

The North Shore-LIJ Health System was founded in 1997 with the merger of the North Shore Health System and LIJ Medical Center, creating a healthcare network that now includes 17 hospitals, The Feinstein Institute for Medical Research, rehabilitation and skilled nursing facilities, a home care network, a hospice network, and progressive care centers offering a range of outpatient services. Headquartered in Great Neck, New York, North Shore-LIJ is the largest integrated health system in New York State, based on patient revenue,[5] and the 14th-largest healthcare system in the United States. Its service area encompasses more than seven million people in Long Island, Manhattan, Queens and Staten Island. With more than 47,000 employees, North Shore-LIJ is the largest private employer in New York State.

The Broad Institute evolved from a decade of informal and successful research collaborations among scientists in the MIT and Harvard communities. In 1990, the Whitehead Institute/MIT Center for Genome Research (WICGR) was founded, and it soon became an international leader in the field of genomics and a flagship of the Human Genome Project. As early as 1995, WICGR scientists recognized the need to bring the power of genomics to the understanding of human disease. It launched pilot projects in genomic medicine, forming an unofficial collaborative network among scientists from across MIT and Harvard who pioneered new approaches to cancer and human genetics. In parallel, Harvard Medical School-based scientists established the Institute of Chemistry and Cell Biology (ICCB) in 1998, to facilitate the pursuit of chemical genetics as an academic discipline and a tool to further understand human biology and disease. In 2002, the ICCB was awarded an Initiative for Chemical Genetics (ICG) grant from the National Cancer Institute, and its successful Investigator-Initiated Screening Program facilitated small molecule screening projects for more than 80 research groups worldwide. These projects demonstrated the power of enabling scientists to collaborate to tackle the major challenges in molecular medicine. It was clear that a new type of formal organization was required — open, collaborative, interdisciplinary, and able to organize projects at any scale. In addition, it was important that the complementary expertise of the genomic scientists and the chemical biologists across MIT and Harvard be brought together in one place to drive the transformation of medicine with molecular knowledge. Discussions in 2002-2003 among Eli and Edythe Broad, MIT, Harvard and its affiliated hospitals, and the Whitehead Institute shaped the vision for this new institute. The extraordinary generosity of Eli and Edythe Broad, through their founding gift of $100 million (later doubled to $200 million) made it possible to formally announce the new institute in June 2003 and to launch it in May 2004. Less than four years after its launch, the Broads gave an unprecedented gift of $400 million in September 2008 to permanently endow the institute, providing long-term sustainability for its unique model of collaborative, inter-institutional research.

Beth Israel Deaconess Medical Center (BIDMC) is one of the nation's preeminent academic medical centers. We are committed to excellence in clinical care, biomedical research and education and to the health and wellness of our patients and our communities. Excellence In Clinical Care Beth Israel Deaconess, a major teaching hospital of Harvard Medical School, is a fully integrated medical center providing adult services from cardiology to obstetrics, gastrointestinal disorders to cancer care. Each year U.S. News & World Report ranks BIDMC as a "Best Hospital" in multiple specialties. As national leaders in patient care quality, safety and transparency, we are setting standards in the way health data can be used to improve care and services. We were the first hospital in the country to achieve meaningful use of electronic medical records, meeting a key set of new federal government standards. BIDMC attracts leading clinicians in all medical fields. Our experts not only provide gold standard treatments to help a patient get better, they also help educate the public on disease prevention. BIDMC clinicians feel a responsibility to do more than make patients better when they are sick-they want to help the community stay healthy. Excellence In Research BIDMC is home to a renowned academic research program, where scientific discoveries help to transform medical care. We rank third in the country for National Institutes of Health funding among independent hospitals. With revolutionary advances and therapies happening within our walls, we are a national and international leader in "bench-to-bedside" research. Our patients benefit directly from our dedication to research. At any given moment, more than 300 clinical trials are offered throughout the medical center for those difficult to treat cases, in areas such as cancer, neurology, cardiology and other medical specialties. Excellence In Education BIDMCs 1,250 full-time physicians constitute almost a quarter of Harvard Medical School's faculty. Because of our roots, we are committed to training the next generation of doctors, and have raised medical education to a higher level with a uniquely strong and deep program that enhances our ability to attract top faculty and residents. Learning flourishes within our hallways, as students learn from the best of the best in an open environment that produces leaders of tomorrow. Advancing Care in Communities In pursuit of clinical and research excellence, we have formed partnerships with outstanding community hospitals, specialty care centers and physician practice groups in eastern Massachusetts to give you and your family the convenience of high quality care, close to home. With BIDMC at the core of this network, access to specialty care downtown is always available when appropriate. We are dedicated to providing the right care, at the right time, in the right place. Blending Warmth and Innovation Compassionate nursing is central to your experience here. Our nurses are highly regarded for superb care, kindness and proficiency. Our quality and safety initiatives, second to none, are often held up as a model for other institutions. As a hospital deemed "Most Wired," and "Most Wireless," we are reengineering how to gather, safeguard and utilize health information. Our systems are state-of-the-art and all BIDMC clinicians use centrally hosted electronic medical records. The Heart of Caring You expect excellence in clinical care, research, education and community outreach from a prominent academic medical center. But we believe what makes BIDMC even more remarkable is our spirit. We treat our patients with the utmost respect and compassion, as we would our own family members and friends.

Non-Profit Donations & Grants
$10K - $25K
2019
$5,000 - $10K
2019
Political Donations
$1,000
2009
$2,000
2003
$1,000
2003
Investments
Details Hidden

Emphasys Medical, Inc., a medical technology company, focuses on developing and commercializing minimally invasive therapeutic devices for the treatment of patients with emphysema and other breathing disorders. It offers Zephyr Endobronchial Valve system, which is designed to block air from passing through the opening in the lung and into the chest cavity, resulting in the reduction or elimination of airflow through the leak to allow the tissue to heal. The company offers its products through distributors and dealers in Europe, Australia, Hong Kong, and Singapore. Emphasys Medical was founded in 2000 and is based in Redwood City, CA. Emphasys Medical, Inc. operates as a subsidiary of Pulmonx Corp.

Details Hidden

Peptimmune was founded in 2002 with technology from the laboratories of Dr. Jack Strominger, Higgins Professor of Biochemistry at Harvard University; and Dr. Hidde Ploegh, from the Whitehead Institute for Biomedical Research. Peptimmune has therapeutics in clinical development for the treatment of multiple sclerosis. Peptimmune's flagship program in multiple sclerosis features PI-2301, which has the opportunity to replace Copaxone® (Teva Pharmaceuticals), the world's leading first-line therapy for the treatment of MS.Peptimmune has broad expertise in MHC Class II molecules and their role in antigen presentation and modulation of immune responses. The Company exploits its proprietary DEEP Technology (Directed Expansion of Epitope Permutation) to design peptides and peptide mixtures for development as therapeutics, diagnostic kits, and as reagents for antibody generation. The Company is building a unique suite of expertise in the manufacture and control of peptide copolymer-based drug products.

Suppliers
Boston Properties, Inc. Trusts & Funds | Boston, MA

Boston Properties, Inc. operates as a real estate investment trust. It develops, redevelops, acquires, manages, and owns aportfolio of Class A properties. It operates through the following geographical segments: Boston, New York, San Francisco, and Washington, DC. The company was founded by Mortimer Benjamin Zuckerman and Edward H. Linde in 1970 and is headquartered in Boston, MA.

Tanseisha Co., Ltd. Other Business & Consulting Services | Tokyo, Japan

TANSEISHA Co., Ltd. engages in the research, planning, design, layout, construction, production and operation of commercial, public, cultural, business and event spaces. Its operations are carried out through the following segments: Commercial and Other Facilities Business, Chain Store Business, Cultural Facilities Business, and Others. The Commercial and Other Facilities Business segment deals with the interior decoration of department stores, specialty stores, restaurants, offices, hotels, and related facilities. The Chain Store Business segment handles the interiors of chain stores offering casual wear and fast food. The Cultural Facilities Business segment manages cultural facilities such as exhibitions in museums and science halls. The Others segment includes the operation and management of commercial facilities; rental and sale of office equipment; dispatch of personnel; and leasing and management of real estate. The company was founded on December 25, 1959 and is headquartered in Tokyo, Japan.

Awards & Honors
Rank #29
2012
The American Lawyer Magazine - The Global 100
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Ropes & Gray LLP. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Ropes & Gray LLP's profile does not indicate a business or promotional relationship of any kind between RelSci and Ropes & Gray LLP.